4//SEC Filing
HEILBRUNN KENNETH R 4
Accession 0001209191-03-022311
CIK 0000920465other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:57 PM ET
Size
9.9 KB
Accession
0001209191-03-022311
Insider Transaction Report
Form 4
HEILBRUNN KENNETH R
VP of Clinical Development
Transactions
- Award
Stock Options (right to buy)
2003-09-18$4.71/sh+11,250$52,988→ 201,250 totalExercise: $4.71Exp: 2013-09-18→ Common Stock (11,250 underlying) - Award
Stock Options (right to buy)
2003-09-18$4.71/sh+33,750$158,963→ 235,000 totalExercise: $4.71Exp: 2013-09-18→ Common Stock (33,750 underlying) - Other
Common Stock
2003-06-30$1.48/sh+1,490$2,204→ 5,956 total
Footnotes (2)
- [F1]Acquired pursuant to the Company???s Employee Stock Purchase Plan.
- [F2]The stock options vest and become exercisable monthly over the next three years.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237530
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:57 PM ET
- Size
- 9.9 KB